###begin article-title 0
###xml 84 88 <span type="species:ncbi:10090">Mice</span>
Loss of Jak2 Selectively Suppresses DC-Mediated Innate Immune Response and Protects Mice from Lethal Dose of LPS-Induced Septic Shock
###end article-title 0
###begin p 1
Conceived and designed the experiments: FG CYW. Performed the experiments: JZ RD. Analyzed the data: JZ PY. Contributed reagents/materials/analysis tools: KM MM. Wrote the paper: FG CYW.
###end p 1
###begin p 2
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 322 327 322 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 312 327 312 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/+</sup>Jak2<sup>fl/fl</sup></italic>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 598 605 598 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 773 776 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 769 776 765 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 824 832 820 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 943 946 939 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 939 946 935 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1150 1153 1146 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1146 1153 1142 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 1154 1158 <span type="species:ncbi:10090">mice</span>
Given the importance of Jak2 in cell signaling, a critical role for Jak2 in immune cells especially dendritic cells (DCs) has long been proposed. The exact function for Jak2 in DCs, however, remained poorly understood as Jak2 deficiency leads to embryonic lethality. Here we established Jak2 deficiency in adult Cre+/+Jak2fl/fl mice by tamoxifen induction. Loss of Jak2 significantly impaired DC development as manifested by reduced BMDC yield, smaller spleen size and reduced percentage of DCs in total splenocytes. Jak2 was also crucial for the capacity of DCs to mediate innate immune response. Jak2-/- DCs were less potent in response to inflammatory stimuli and showed reduced capacity to secrete proinflammatory cytokines such as TNFalpha and IL-12. As a result, Jak2-/- mice were defective for the early clearance of Listeria after infection. However, their potency to mediate adaptive immune response was not affected. Unlike DCs, Jak2-/- macrophages showed similar capacity secretion of proinflammatory cytokines, suggesting that Jak2 selectively modulates innate immune response in a DC-dependent manner. Consistent with these results, Jak2-/- mice were remarkably resistant to lethal dose of LPS-induced septic shock, a deadly sepsis characterized by the excessive innate immune response, and adoptive transfer of normal DCs restored their susceptibility to LPS-induced septic shock. Mechanistic studies revealed that Jak2/SATA5 signaling is pivotal for DC development and maturation, while the capacity for DCs secretion of proinflammatory cytokines is regulated by both Jak2/STAT5 and Jak2/STAT6 signaling.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 86 89 86 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Wen1">[1]</xref>
###xml 301 304 301 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Steinman1">[2]</xref>
###xml 305 308 305 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Hoebe1">[4]</xref>
###xml 775 778 775 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Sriskandan1">[5]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Xiao1">[10]</xref>
###xml 1093 1097 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Das1">[11]</xref>
###xml 1099 1103 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Rivers1">[12]</xref>
###xml 1210 1214 1210 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Nelson1">[13]</xref>
###xml 1215 1219 1215 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Sakr1">[15]</xref>
###xml 1453 1457 1453 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Efron1">[16]</xref>
###xml 960 968 <span type="species:ncbi:9606">patients</span>
Dendritic cells (DCs) are the most potent antigen presenting cells (APCs) known today [1]. Other than their well-recognized role in mediating adaptive immune response, they also serve as a key component of innate immunity and bridge innate and adaptive immune response to bacteria and other pathogens [2]-[4]. The pathogen associated molecular patterns (PAMPs) or damage associated molecular patterns (DAMPs) are first sensed by pathogen recognition receptors (PRRs) expressed on their surface, followed by initiating a serial prompt responses such as endocytosis and cytokine secretion. Immune disorders are a system out of balance as manifested by either excessive or defective response, and septic shock is a typical example caused by the excessive innate immune response [5]-[10]. Septic shock (or endotoxic shock) is a severe sepsis with organ hypoperfusion and hypotension that are poorly responsive to initial fluid resuscitation. The mortality rate in patients with septic shock ranges from 20 to 80%, and in the USA alone it is estimated that more than 100,000 deaths occur each year [11], [12]. Therefore, septic shock has been accounted for the most common cause of death in the intensive care unit [13]-[15]. Given the importance of DCs in the vanguard of innate immune response, research into the development of new septic therapeutics has focused more and more on their crucial role in orchestrating the initial host response to infection [16], but the advancement has been painfully slow and fraught with difficulties. The ideal therapeutic target for septic shock would be directed to selectively modulate innate immune response without affecting adaptive defense. Nevertheless, it would be a formidable challenge to characterize such a target among all immune regulatory molecules within the genome.
###end p 4
###begin p 5
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Ihle1">[17]</xref>
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Sandberg1">[18]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Lang1">[19]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Watanabe1">[21]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Shuai1">[22]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Laffort1">[25]</xref>
###xml 545 550 545 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 541 550 541 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>fl/fl</sup></italic>
###xml 791 794 791 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 787 794 787 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 570 585 <span type="species:ncbi:10090">transgenic mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
Jak2 is one of the four janus kinase members identified in mammals [17], [18]. It acts as a critical component of signal pathways involved in cellular survival, proliferation, differentiation and apoptosis [19]-[21]. Particularly, Jak2 has been suggested to be crucial for the regulation of DC development and functionality [22]-[25]. However, the exact function for Jak2 in DCs remained, somehow, controversial depending on each particular chemical inhibitor used. In the present study, we induced Jak2 deficiency in adult mice by crossing Jak2fl/fl mice with Cre-ERT2 transgenic mice. Loss of Jak2 only selectively suppresses the capacity of DCs to initiate innate immune response, but there is no discernable impact on their capacity to mediate adaptive immune response. As a result, Jak2-/- mice are remarkably resistant to lethal dose of LPS-induced septic shock. Our results suggest that Jak2 could be a unique therapeutic target for the intervention and treatment of clinical septic shock.
###end p 5
###begin title 6
Results
###end title 6
###begin title 7
Jak2 Is Essential for DC Development and Maturation
###end title 7
###begin p 8
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 10 15 10 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/+</sup>Jak2<sup>fl/fl</sup></italic>
###xml 82 87 82 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 78 87 78 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>fl/fl</sup></italic>
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 165 170 165 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 155 170 155 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/+</sup>Jak2<sup>fl/fl</sup></italic>
###xml 589 598 589 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figure 1A</xref>
###xml 900 903 900 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 907 912 907 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 897 912 897 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/+</sup>Jak2<sup>fl/fl</sup></italic>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 57 72 <span type="species:ncbi:10090">transgenic mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:381124">corn</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
Cre+/+Jak2fl/fl mice were generated by crossing Cre-ERT2 transgenic mice with Jak2fl/fl mice as described. For induction of Jak2 deficiency, 8 wk-old male Cre+/+Jak2fl/fl mice were i.p. injected with tamoxifen (25 mg/kg body weight) for five consecutive days. Male littermates administered with carrier solution (10% ethanol in corn oil) were used as controls. To confirm Jak2 deficiency, the mice were sacrificed after 2 wk of last injection. Bone marrow derived dendritic cells (BMDCs) and splenocytes were prepared and subjected to Western blot analysis of Jak2 expression. As shown in Figure 1A, BMDCs originated from control mice showed high levels of Jak2 expression, while Jak2 was undetectable in BMDCs of tamoxifen induced mice. Similar results were also observed in splenocytes (data not shown). Collectively, these results indicate that tamoxifen efficiently induced Jak2 deficiency in Cre+/+Jak2fl/fl mice.
###end p 8
###begin title 9
Jak2 is essential for DC development and maturation.
###end title 9
###begin p 10
###xml 87 90 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 94 99 94 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 84 99 84 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/+</sup>Jak2<sup>fl/fl</sup></italic>
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 570 573 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 566 573 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 751 754 751 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 747 754 747 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 808 811 808 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 804 811 804 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 928 931 928 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 924 931 924 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1501 1502 1499 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1513 1514 1511 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1526 1527 1524 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
(A) Tamoxifen efficiently induced Jak2 deficiency in DCs. BMDCs were generated from Cre+/+Jak2fl/fl mice after 2 wk of tamoxifen or carrier solution induction and then subjected to Western blot analysis of Jak2 expression. High levels of Jak2 were detected in control mice, while Jak2 was absent in tamoxifen induced mice. (B) Loss of Jak2 significantly reduced BMDC yield. Bone marrow cells (1x107) were used to generate BMDCs using GM-CSF (10 ng/ml) and IL-4 (5 ng/ml) as described. Bone marrow cells deficient for Jak2 showed 1.3-fold decrease of BMDC yield. (C) Jak2-/- mice show significant smaller spleen size. Top panel: a bar graphic figure showing the average spleen weight of all mice analyzed; bottom panel: representative spleens from Jak2-/- and control mice. (D) Analysis of splenocytes in Jak2-/- and control mice. Both total splenocytes and the percentage of splenic DCs in total splenocytes were reduced in Jak2-/- mice as compared with that of controls. (E) BMDC surface marker expressions in the unstimulated condition. Left panel: a representative of flow cytometry data; right panel: a bar graphic figure showing the average percentage of BMDCs positive for each surface marker analyzed. (F) BMDC surface marker expressions after LPS stimulation. Similar as above, left panel is a representative of flow cytometry data, and right panel shows the average percentage of BMDCs positive for the corresponding surface marker. All data are present as mean +/- SE of four replicates. *, p<0.05; **, p<0.01; ***, p<0.001.
###end p 10
###begin p 11
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 336 339 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 384 393 384 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figure 1B</xref>
###xml 458 461 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 454 461 454 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 521 522 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 530 539 526 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figure 1C</xref>
###xml 598 601 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 594 601 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 654 675 650 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figure 1D, left panel</xref>
###xml 852 874 848 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figure 1D, right panel</xref>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
We first sought to address the impact of Jak2 deficiency on DC development. To this end, 1x107 bone marrow cells originated from Jak2-/- and control littermates were induced with GM-CSF and IL-4 to generate BMDCs, respectively. Jak2 deficiency significantly reduced DC production, a 1.3-fold decrease for BMDC yield was observed in Jak2-/- mice as compared with that of control mice (Figure 1B). We also noticed a significant smaller size for spleens in Jak2-/- mice than that of control mice (52+/-8 mg vs. 157+/-10 mg, p<0.001; Figure 1C). In line with this observation, total splenocytes in Jak2-/- mice were significantly less than that of controls (Figure 1D, left panel). Next, we examined splenic DCs. To our surprise, in addition to the reduced number of total splenocytes, the percentage of DCs in spenocytes has also significantly decreased (Figure 1D, right panel). In contrast, we failed to detect a significant alteration for the percentage of CD4 and CD8 T cells in total spenocytes (data not shown). Together, these data suggest that loss of Jak2 significantly impaired DC development.
###end p 11
###begin p 12
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 256 259 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 252 259 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 450 454 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Nefedova1">[26]</xref>
###xml 456 460 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Nefedova2">[27]</xref>
###xml 602 605 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 598 605 594 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 707 716 703 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figure 1E</xref>
###xml 908 911 904 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 904 911 900 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 934 943 930 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figure 1F</xref>
###xml 1193 1196 1189 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1189 1196 1185 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1270 1279 1266 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s001">Figure S1</xref>
###xml 1422 1426 1418 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Nefedova2">[27]</xref>
###xml 1481 1484 1477 1480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1477 1484 1473 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1537 1546 1533 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s002">Figure S2</xref>
###xml 1650 1659 1646 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s003">Figure S3</xref>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 1485 1489 <span type="species:ncbi:10090">mice</span>
We next examined DC phenotypic differences between Jak2-/- and control mice. For this purpose, day-9 BMDC cultures were stimulated with 0.5 microg/ml LPS overnight and harvested on day-10 for flow cytometry analysis of surface marker expressions. Both Jak2-/- and control bone marrow cells produced >85% purity of DCs, which were then gated for the analysis of surface MHC-II, CD80, CD86, and CD54 expressions. In contrast to previous published data [26], [27], loss of Jak2 rendered DCs significant less potent in response to maturation stimulation. We first noticed that much lower percentage of Jak2-/- BMDCs expressing MHC-II and co-stimulatory molecules such as CD80, CD86 and CD54 before stimulation (Figure 1E). Upon LPS stimulation, majority of control BMDCs became matured as characterized by high levels of MHC-II, CD80, CD86 and CD54 expressions. In sharp contrast, only a small proportion of Jak2-/- BMDCs became matured (Figure 1F). To further confirm this observation, we analyzed splenic DCs. Single splenic cells were prepared and then co-stained for CD11c and MHC-II or one of the above indicated costimulatory molecules. Similar as BMDCs, significant lower percentage of Jak2-/- splenic DCs expressed high levels of MHC-II and costimulatory molecules (Figure S1). To further confirm these observations, we treated BMDCs with AG490, a broadly used Jak2 inhibitor. In contrast to previously published data [27], but consistent with our current data observed on Jak2-/- mice, AG490 significantly suppressed DC maturation (Figure S2). We also tested the impact of tamoxifen on DC maturation and failed to detect any perceptible effect (Figure S3).
###end p 12
###begin p 13
###xml 271 274 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 568 571 568 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 564 571 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 624 627 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 620 627 620 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 804 813 804 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s004">Figure S4</xref>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
We next examined the impact of Jak2 deficiency on macrophages, another important type of professional APCs. Peritoneal exudate macrophages (PEM) were collected by peritoneal lavage as described. Western blot analysis confirmed the absence of Jak2 in PEM derived from Jak2-/- mice (data not shown). The cells were then subjected to flow cytometry analysis as above. To our surprise, we failed to observe a significant difference for the number of macrophages between Jak2-/- and control mice, and Western analysis also confirmed Jak2 deficiency in PEM derived from Jak2-/- mice (data not shown). However, similar as DCs, Jak2-/- macrophages showed a less matured phenotype characterized by the lower percentage of cells expressing MHC-II and costimulatory molecules as compared with that of control mice (Figure S4).
###end p 13
###begin title 14
Jak2 Deficiency Attenuates the Capacity of DCs to Initiate Innate Immune Response
###end title 14
###begin p 15
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 218 221 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 214 221 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 298 301 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 294 301 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 360 369 352 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g002">Figure 2A</xref>
###xml 469 472 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 465 472 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 568 577 552 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g002">Figure 2A</xref>
###xml 612 615 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 608 615 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 670 680 654 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s005">Figure S5A</xref>
###xml 733 736 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 729 736 713 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 891 894 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 887 894 867 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1013 1022 989 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g002">Figure 2B</xref>
Next, we examined the capacity of Jak2-/- DCs secretion of proinflammatory cytokines such as TNFalpha and IL-12 using the above culture supernatants. Before stimulation IL-12 was undetectable in both wild-type and Jak2-/- cultures, while low levels of TNFalpha were detected, but the amount in Jak2-/- cultures was 12-fold lower than that of control cultures (Figure 2A). Upon LPS stimulation BMDCs secreted copious amounts of TNFalpha and IL-12, and consistently, Jak2-/- BMDCs secreted much lower levels of TNFalpha and IL-12 as compared with that of control BMDCs (Figure 2A). However, both wild-type and Jak2-/- BMDCs showed similar capacity for secretion of IL-10 (Figure S5A).Similarly, we analyzed cytokine secretion from Jak2-/- macrophages. Supernatants harvested from above PEM cultures were examined for TNFalpha and IL-12 production by ELISA assay. Very surprisingly, unlike Jak2-/- DCs, macrophages deficient for Jak2 showed similar capacity to secrete TNFalpha and IL-12 as that of wild-type cells (Figure 2B). All together, these data suggest that loss of Jak2 only selectively impairs the capacity of DCs to initiate innate immune response.
###end p 15
###begin title 16
Jak2 deficiency selectively attenuates the capacity of DCs to initiate innate immune response.
###end title 16
###begin p 17
###xml 423 426 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 419 426 415 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 573 576 569 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 569 576 565 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 617 625 613 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 631 634 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 627 634 623 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 696 718 680 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria Monocytogenes</italic>
###xml 1110 1111 1092 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1122 1123 1104 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1135 1136 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
(A) Loss of Jak2 attenuates the capacity of DCs secretion of proinflammatory cytokines. Supernatants of BMDCs with or without LPS stimulation were harvested and subjected to ELISA analysis of cytokine secretion. BMDCs deficient for Jak2 showed significant reduced capacity to secrete TNFalpha and IL-12. (B) Jak2 failed to show perceptible impact on macrophages secretion of proinflammatory cytokines. PEM derived from Jak2-/- and control mice were cultured with or without LPS stimulation and supernatants were harvested for ELISA analysis as above, respectively. (C) Jak2-/- mice showed impaired early clearance of Listeria. Jak2-/- and control mice were i.v. injected with approximately1 LD50 Listeria Monocytogenes in PBS. Spleens and livers were harvested after 48 h infection. Serial 10-fold dilutions of organ homogenates were plated on TSB-agar and CFU were counted after 48 h incubation. Left panel: a representative results for cultures inoculated with homogenates; right panel: a bar graphic figure showing the average CFU/organ of 3 independent experiments. All data are present as mean +/- SE. *, p<0.05; **, p<0.01; ***, p<0.001.
###end p 17
###begin p 18
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 206 214 206 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Cousens1">[28]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Serbina1">[31]</xref>
###xml 319 320 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 343 345 331 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 350 358 338 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 380 383 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 376 383 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 604 607 592 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 600 607 588 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 670 678 658 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 739 742 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 735 742 723 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 787 796 775 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g002">Figure 2C</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">Mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
To further confirm above observations, we checked Listeria clearance in Jak2-/- mice as innate immunity especially the production of proinflammatory cytokines plays a pivotal role in the early clearance of Listeria after infection [28]-[31]. For this purpose, Mice were systemically infected by i.v. injection with 1x106 CFU (approximately1 LD50) of Listeria, and organs from Jak2-/- and control mice were harvested after 2-day of infection. Dilutions of spleen and liver homogenates were plated on TSB-agar and colonies were counted after 2-day of culture, respectively. In line with above results, Jak2-/- mice showed significant lower capacity for early clearance of Listeria as manifested by 50-100 times more colonies observed in Jak2-/- mice as compared with that of control mice (Figure 2C).
###end p 18
###begin title 19
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
Jak2-/- DCs Possess Similar Capacity to Mediate Adaptive Immune Response
###end title 19
###begin p 20
###xml 262 265 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 258 265 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 536 557 536 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g003">Figure 3A, left panel</xref>
###xml 667 670 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 663 670 663 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 859 862 859 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 855 862 855 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 924 946 924 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g003">Figure 3A, right panel</xref>
###xml 986 989 986 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 982 989 982 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1075 1078 1075 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1071 1078 1071 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1213 1216 1209 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1209 1216 1205 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1300 1309 1296 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g003">Figure 3B</xref>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
The above results prompted us to check whether Jak2 deficiency would affect the capability of DCs to mediate adaptive immune response. We first performed allogenic MLR to examine the capacity of DCs to stimulate T cell proliferation. To this end, irradiated Jak2-/- and control BMDCs were cocultured with T cells originated from BALB/c mice, and T cell proliferation was determined by 3H thymidine incorporation. Unexpectedly, Jak2-/- BMDCs showed similar potency as control BMDCs to stimulate alloreactive BALB/c T cell proliferation (Figure 3A, left panel). To confirm this observation, we performed similar studies using splenic DCs. Splenocytes pooled from 5 Jak2-/- or control mice were used to enrich splenic DCs as described. Irradiated splenic DCs (2000 rads) were then cocultured with BALB/c T cells as above, respectively. Consistently, splenic Jak2-/- DCs were potent to stimulate alloreactive T cell activation (Figure 3A, right panel). We next examined the capacity of Jak2-/- DCs to initiate antigen-specific T cell activation. For this purpose, irradiated Jak2-/- BMDCs or splenic DCs were first pulsed with 1 microM OVA peptide, and then cocultured with OT-1 T cells as above. Similarly, both Jak2-/- BMDCs and splenic DCs were potent to stimulate antigen-specific T cell activation (Figure 3B).
###end p 20
###begin title 21
DCs deficient for Jak2 show similar potency to stimulate T cell activation.
###end title 21
###begin p 22
###xml 313 314 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
(A) Allogenic MLR results. (B) Antigen-specific MLR results. (C) ELISA analysis of cytokines produced by the activated T cells. MLR were carried out using either BALB/c T cells (allogenic) or OT-1 T cells (antigen-specific) as responders in the condition of DC/T ratio 1:10. T cell proliferation was estimated by 3H thymidine incorporation. Data shown in the figure are mean +/- SE of three independent experiments performed.
###end p 22
###begin p 23
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 235 238 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 231 238 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 336 345 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g003">Figure 3C</xref>
Next, we analyzed cytokine profile of T cells activated by Jak2-/- DCs. We selectively analyzed the production of IFN-gamma (Th1), IL-10 (Th2) and IL-17 (Th17) by ELISA analysis of above collected culture supernatants. Once again, Jak2-/- DCs were as potent as control DCs to stimulate T cells secretion of IFN-gamma, IL-10, and IL-17 (Figure 3C). Taken together, these results indicate that loss of Jak2 only selectively inhibits the potency of DCs to initiate innate immune response without perceptible effect on DC-mediated adaptive immune response.
###end p 23
###begin title 24
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
Jak2-/- Mice Are Remarkably Resistant to Lethal Dose of LPS-Induced Septic Shock
###end title 24
###begin p 25
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Warner1">[32]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-CarrilloEsper1">[34]</xref>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 299 304 299 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 289 304 289 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/+</sup>Jak2<sup>fl/fl</sup></italic>
###xml 471 474 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 566 569 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 717 720 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 713 720 713 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 787 796 787 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g004">Figure 4A</xref>
###xml 811 812 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 465 470 <span type="species:ncbi:10090">mouse</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
Given the role that Jak2 selectively regulates DC-mediated innate immune response, we next examined its implication in the pathogenesis of septic shock, in which excessive innate immune response is suggested to be responsible for the disease etiology [32]-[34]. To this end, 8 wk-old male Cre+/+Jak2fl/fl mice were first induced with tamoxifen or control vehicle as above. Four weeks later, lethal dose of LPS (50 mg/kg body weight) was then administered into each mouse via i.p. injection. In general, all control mice were much weaker as compared with that of Jak2-/- mice after 6-12 h of injection, and remarkably, 14 out of 18 control mice (78%) died within 36 h of injection. In sharp contrast, 17 out of 20 Jak2-/- mice have completely recovered from lethal dose of LPS challenge (Figure 4A, 85% vs. 22%, p<0.0001), indicating that loss of Jak2 protected mice from lethal dose of LPS-induced septic death.
###end p 25
###begin title 26
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Jak2-/- mice show DC-dependent resistance to lethal dose of LPS-induced septic shock.
###end title 26
###begin p 27
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 253 260 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 453 456 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 449 456 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 536 539 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 532 539 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 656 660 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2</italic>
###xml 830 833 830 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 826 833 826 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 945 948 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 941 948 941 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1235 1238 1231 1234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1231 1238 1227 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1406 1407 1400 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1418 1419 1412 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1431 1432 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1027 1032 <span type="species:ncbi:10090">mouse</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
(A) The survival rates of Jak2-/- and control mice were monitored for 4 days after lethal dose of LPS challenge. It was noticed that mice would completely recover from septic shock if they did not die within 36 h of lethal dose of LPS challenge. 85% of Jak2-/- mice (17 out of 20) have completely recovered from septic shock, while only 22% of control mice (4 out of 18) have survived (p<0.0001). (B) Adoptive transfer of normal DCs into irradiated Jak2-/- mice restored their susceptibility to LPS-induced septic shock. Irradiated Jak2-/- or control mice were first adoptively transferred with 1x107 normal BMDCs followed by lethal dose of LPS challenge. Jak2-/- mice after adoptive transfer of normal DCs showed similar survival rate as that of control mice, indicating that the resistant phenotype for septic shock seen in Jak2-/- mice is DC-dependent. (C) ELISA analysis of serum cytokines of nonlethal dose of LPS challenged mice. Both Jak2-/- and control mice were first challenged with nonlethal dose of LPS (150 microg/mouse) and 12 h later the mice were sacrificed, respectively. Sera were pooled from three mice and then subjected to ELISA analysis of cytokine production. Three pools were analyzed for each study group. Jak2-/- mice produced significant lower levels of proinflammatory cytokines as compared with that of control mice. The data are present as mean +/- SE of three replicates. *, p<0.05; **, p<0.01; ***, p<0.001.
###end p 27
###begin p 28
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 369 376 369 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 459 468 459 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g004">Figure 4B</xref>
###xml 565 568 565 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 561 568 561 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
To confirm that the protective effect observed in Jak2-/- mice was DC-dependent, we next performed an adoptive transfer study using DCs originated from wild-type mice. To this end, the irradiated Jak2-/- mice and their corresponding controls were adoptively transferred 1x107 normal BMDCs followed by challenging with lethal dose of LPS as described. As expected, both Jak2-/- and control mice showed similar survival rate after lethal dose of LPS challenge (Figure 4B), demonstrating that DCs with reduced capacity to initiate innate immune response protected Jak2-/- mice from septic shock.
###end p 28
###begin p 29
###xml 192 195 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 188 195 180 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 383 386 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 379 386 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 493 502 481 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g004">Figure 4C</xref>
###xml 572 575 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 568 575 556 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 615 618 603 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 611 618 599 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 657 666 645 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g004">Figure 4C</xref>
###xml 770 773 758 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 766 773 754 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 812 822 800 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s005">Figure S5B</xref>
###xml 1128 1131 1112 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1124 1131 1108 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1151 1161 1135 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s006">Figure S6A</xref>
###xml 1212 1215 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1208 1215 1192 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1304 1314 1284 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s006">Figure S6B</xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 1216 1220 <span type="species:ncbi:10090">mice</span>
###xml 1261 1266 <span type="species:ncbi:10090">mouse</span>
To further address above question, we examined serum TNFalpha and IL-12 production in mice challenged with nonlethal dose of LPS (150 microg/mouse). Serum samples were collected from both Jak2-/- and control mice after 12 h of LPS challenge. Sera pooled from 3 mice of each study group were subjected to ELISA analysis of cytokine production. Consistent with above observations, Jak2-/- mice produced significant lower levels of serum TNFalpha and IL-12 as compared with that of control mice (Figure 4C). Interestingly, we observed much higher levels of serum IL-2 in Jak2-/- mice although IL-2 levels for both Jak2-/- and control mice were relatively low (Figure 4C). Similar as in vitro studies, we failed to detect significant differences for serum IL-10 between Jak2-/- and control mice after LPS challenge (Figure S5B). As DC apoptosis is a potential causative factor for post-septic death, we examined DC apoptosis by flow cytometry. BMDCs were treated with 10 microg/ml LPS for 96 h and then stained with Annexin-V and PI for flow cytometry analysis. We failed to detect a significant difference of apoptosis between Jak2-/- and control BMDCs (Figure S6A). We further analyzed splenic DC apoptosis in Jak2-/- mice after 20 h of LPS challenge (150 microg/mouse), and similar results were obtained (Figure S6B).
###end p 29
###begin title 30
Loss of Jak2 Impairs the Activation of STAT3, 4, 5, and 6
###end title 30
###begin p 31
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 110 117 110 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 495 498 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 491 498 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 518 527 486 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g005">Figure 5A</xref>
###xml 1130 1139 1094 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g005">Figure 5B</xref>
###xml 1150 1159 1114 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g005">Figure 5C</xref>
###xml 1170 1179 1134 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g005">Figure 5D</xref>
###xml 1193 1202 1157 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g005">Figure 5E</xref>
###xml 1278 1287 1242 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g005">Figure 5F</xref>
###xml 1473 1476 1437 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1469 1476 1433 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1584 1593 1548 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s007">Figure S7</xref>
To investigate the underlying mechanisms by which Jak2 regulates DC-mediated innate immune response, 2x106/ml Jak2-/- or control BMDCs were stimulated with 1 microg/ml LPS for 30 min and then harvested for Western blot analysis of target molecules. Given the importance of NFkappaB signaling in LPS-induced immune response, we first examined phosphorylated IkappaBalpha (pIkappaBalpha) in BMDC lysates. To our surprise, we failed to detect a significant difference for pIkappaBalpha between Jak2-/- and control BMDCs (Figure 5A). Therefore, Jak2 regulation of DCs for secretion of proinflammatory cytokines seems to be independent of NFkappaB signaling. We next examined the activation states of downstream signaling molecules. As STAT signaling has been demonstrated to be crucial for cytokine receptors to transduce intracellular signals, we therefore checked the phosphorylation states of transcription factors STAT1, STAT3, STAT4, STAT5 and STAT6. It was found that loss of Jak2 significantly attenuated STAT3, 4, 5 and 6 activation in BMDCs as manifested by the significant decreased levels for phosphorylated STAT3 (pSTAT3, Figure 5B), pSTAT4 (Figure 5C), pSTAT5 (Figure 5D) and pSTAT6 (Figure 5E). In contrast, Jak2 did not show a perceptible effect on STAT1 activation (Figure 5F). To demonstrate why macrophages deficient for Jak2 showed similar capacity secretion of proinflammatory cytokines, we further examined the activation states of all STAT factors in Jak2-/- macrophages as above. Unlike DCs, loss of Jak2 in macrophages only affected the activation of STAT3 and 4 (Figure S7).
###end p 31
###begin title 32
Western blot analysis of the activation states of Jak2 downstream molecules.
###end title 32
###begin p 33
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
2x106/ml Jak2-/- and control BMDCs were harvested after 30 min of LPS stimulation (1 microg LPS/ml) and cell lysates were prepared for Western blot analysis of the phosphorylated form of signaling molecules. (A) pIkappaBalpha; (B) phosphorylated STAT3 (pSTAT3); (C) pSTAT4; (D) pSTAT5; (E) pSTAT6; and (F) pSTAT1. Four independent experiments were performed and consistent results were obtained.
###end p 33
###begin title 34
Jak2/STAT5 Signaling Is Indispensable for DC Development and Maturation
###end title 34
###begin p 35
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 167 174 167 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 316 325 316 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6A</xref>
###xml 460 481 460 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6B, left panel</xref>
###xml 603 625 603 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6B, right panel</xref>
###xml 882 891 882 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6C</xref>
###xml 1237 1242 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat5</italic>
###xml 1346 1355 1342 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6D</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
We next sought to examine the functional relevance of Jak2/STAT5 signaling in DCs. Stat5-Tg mice and their control littermates were used for the study. In contrast to Jak2-/- mice, the weight of spleens and number of splenocytes were significantly higher in Stat5-Tg mice as compared with their control littermates (Figure 6A). Consistent with this observation, the yield of BMDCs from Stat5-Tg mice was 1.6-fold higher than that of their control littermates (Figure 6B, left panel). Similarly, the percentage of splenic DCs in total splenocytes was significantly higher than their control littermates (Figure 6B, right panel). We further examined the impact of Jak2/STAT5 signaling on DC maturation. Similar as above, DCs were generated from bone marrow cells originated from Stat5-Tg mice and control littermates, respectively, and then stimulated with LPS overnight. As shown in Figure 6C, significant higher percentage of BMDCs derived from Stat5-Tg mice expressing high levels of MHC-II and costimulatory molecules such as CD80, CD86 and CD54 before and after LPS stimulation, as compared with their control littermates. We next examined cytokine secretion using the above culture supernatants. Interestingly, BMDCs with transgenic Stat5 expression showed similar capacity to secret TNFalpha, however, much higher levels of IL-12 was noted (Figure 6D). Together, our results suggest that Jak2/STAT5 signaling plays an indispensable role in DC development, maturation and IL-12 secretion.
###end p 35
###begin title 36
Jak2/STAT5 signaling is indispensable for DC development and maturation, while the capacity of DC for secretion of proinflammatory cytokines is regulated by both Jak2/STAT5 and Jak2/STAT6 signaling.
###end title 36
###begin p 37
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat5</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat5</italic>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat5</italic>
###xml 788 791 784 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 783 791 779 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4<sup>&#8722;/&#8722;</sup></italic>
###xml 801 804 797 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 796 804 792 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 816 819 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 811 819 807 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 936 939 928 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 931 939 923 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4<sup>&#8722;/&#8722;</sup></italic>
###xml 1054 1059 1046 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat3</italic>
###xml 1126 1131 1118 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat3</italic>
###xml 1612 1613 1598 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1624 1625 1610 1611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1637 1638 1623 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
(A) Stat5-Tg mice show larger size for the spleen and higher number of splenocytes. (B) Transgenic Stat5 expression enhances BMDC yield and increases the percentage of splenic DCs in total splenocytes (C) DCs with transgenic Stat5 expression show higher potency in response to LPS stimulation. Significant higher percentage of DCs show matured phenotype as characterized by high levels of MHC II and costimulatory molecule expressions before/after LPS stimulation. (D) ELISA analysis of cytokines secreted by DCs with transgenic Stat5 expression. Stat5-Tg BMDCs showed similar capacity for secretion of TNFalpha, while the production of IL-12 was significantly higher than that of control BMDCs after LPS stimulation. (E) ELISA analysis of cytokine secretion by BMDCs generated from Stat4-/- and Stat6-/- mice. Stat6-/- BMDCs showed significant lower capacity for secretion of TNFalpha and IL-12 upon LPS stimulation. In contrast, Stat4-/- BMDCs showed similar capacity for secretion of above indicated cytokines as control BMDCs. (F) Down-regulation of Stat3 in DC2.4 cell by siRNA. DC2.4 cells were first transfected with a Stat3-specific siRNA or a scramble RNA followed by LPS stimulation for analysis of cytokine secretion. Left panel: Western blot results showing significant down-regulation of pSTAT3 in cells transfected with siRNA. Right panel: ELISA analysis of cytokine secretion. IL-12 was undetectable in both siRNA and scramble transfected DC2.4 cells, while siRNA transfected DC2.4 cells showed similar capacity for secretion of TNFalpha. Data shown in the figure are presented as mean +/- SE. *, p<0.05; **, p<0.01; ***, p<0.001.
###end p 37
###begin title 38
Jak2/STAT6 Is Essential for DCs Secretion of Proinflammatory Cytokines
###end title 38
###begin p 39
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4<sup>&#8722;/&#8722;</sup></italic>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 138 146 138 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 285 293 285 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4<sup>&#8722;/&#8722;</sup></italic>
###xml 303 306 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 298 306 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 555 564 551 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6E</xref>
###xml 655 658 647 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 650 658 642 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 795 798 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 790 798 774 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 836 845 820 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6E</xref>
###xml 1270 1274 1250 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Chiang1">[35]</xref>
###xml 1446 1449 1426 1429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1442 1449 1422 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1609 1612 1585 1588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1605 1612 1581 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 1462 1466 <span type="species:ncbi:10090">mice</span>
###xml 1613 1617 <span type="species:ncbi:10090">mice</span>
To delineate whether Jak2/STAT4 and Jak2/STAT6 signaling implicate in DC development and DC-mediated innate immune response, Stat4-/- and Stat6-/- mice were used for the study. It is noteworthy that we failed to detect significant alterations for DC development and maturation in both Stat4-/- and Stat6-/- mice (data not shown). As a result, our next focus is to examine their implications in the regulation of cytokine secretion. Before stimulation, BMDCs only secreted low levels of TNFalpha, while IL-12 was undetectable in the cultures of all BMDCs (Figure 6E). However, high levels of TNFalpha and IL-12 were detected after LPS stimulation and Stat6-/- BMDCs showed significant lower capacity to secret TNFalpha and IL-12, although we observed relatively higher levels of TNFalpha in Stat6-/- BMDCs in the unstimulated condition (Figure 6E). All of these results demonstrate that Jak2/STAT6 signaling regulates the capacity of DCs to secrete cytokines implicated in innate immune response. To our surprise, we failed to detect a significant impact for Jak2/STAT4 signaling on either DC development or cytokine secretion. Previous studies demonstrated that STAT4 levels directly correlate with IL-12-dependent IFNgamma production by DCs during antigen presentation [35], it is possible that Jak2/STAT4 signaling implicates in DC-mediated T cell polarization. Consistent with this assumption, we failed to detect DCs originated from both Jak2-/- and control mice secretion of IFNgamma after LPS stimulation despite lower percentage of DCs carrying high levels of MHC-II and costimulatory molecules in Jak2-/- mice (data not shown).
###end p 39
###begin p 40
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat3</italic>
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Takeda1">[36]</xref>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat3</italic>
###xml 349 370 349 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6F, left panel</xref>
###xml 739 761 735 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6F, right panel</xref>
###xml 920 925 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat3</italic>
###xml 964 968 960 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Coffer1">[37]</xref>
###xml 969 973 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Park1">[39]</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
As mice deficient for Stat3 lead to embryonic lethality [36], we used DC2.4 cells, a B6-derived DC line, for the study. DC2.4 cells were transfected with a Stat3 siRNA or a scramble RNA as described. Western blot analysis confirmed a significant reduction for the active form of STAT3 in response to LPS stimulation in cells transfected with siRNA (Figure 6F, left panel). Culture supernatants were then collected and subjected to analysis of proinflammatory cytokine secretion. To our surprise, we failed to detect IL-12 production in all cultures either before or after LPS stimulation. However, DC2.4 cells secreted high levels of TNFalpha, but no significant difference was noted between cells transfected with siRNA and scramble RNA (Figure 6F, right panel), indicating that Jak2/STAT3 signaling may not affect the capacity of DCs secretion of proinflammatory cytokines. Several recent studies suggested a role for Stat3 in DC development and differentiation [37]-[39], and therefore, Jak2/STAT3 is possibly to work together with Jak2/STAT5 signaling involved in DC development.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Nefedova1">[26]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Nefedova2">[27]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Chiang1">[35]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Nefedova3">[40]</xref>
###xml 564 569 564 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 560 569 560 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>fl/fl</sup></italic>
###xml 863 875 863 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figures 1B&#8211;D</xref>
###xml 1035 1038 1035 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1031 1038 1031 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1109 1124 1109 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g001">Figures 1E &amp; 1F</xref>
###xml 1271 1280 1267 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g002">Figure 2A</xref>
###xml 1300 1303 1296 1299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1296 1303 1292 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1351 1359 1347 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 1415 1424 1411 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g002">Figure 2C</xref>
###xml 1575 1587 1571 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g003">Figures 3A&#8211;C</xref>
###xml 1809 1818 1801 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g002">Figure 2B</xref>
###xml 2015 2023 2007 2015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g005">Figure 5</xref>
###xml 2091 2094 2083 2086 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2087 2094 2079 2086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 2108 2117 2100 2109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s007">Figure S7</xref>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 589 604 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1304 1308 <span type="species:ncbi:10090">mice</span>
###xml 1409 1413 <span type="species:ncbi:10090">mice</span>
Given the importance of Jak2 in both physiological and pathological conditions, a critical role for Jak2 in immune cells especially DCs has long been proposed. However, despite past extensive studies, its exact function in DCs remains controversial [26], [27], [35], [40]. The main reason for the discrepant results is that most studies were conducted using Jak2 inhibitors as loss of Jak2 is embryonic lethal, while those inhibitors could non-specifically target other molecules. In this study, we have generated an inducible Jak2 deficient model by crossing Jak2fl/fl mice with Cre-ERT2 transgenic mice. We first performed studies to examine the implication of Jak2 in DC development. We have demonstrated that loss of Jak2 impairs DC development as manifested by the reduced BMDC yield, smaller spleen size, and reduced percentage of DCs in total splenocytes (Figures 1B-D). Other than this recognized role, we further noticed a pivotal role for Jak2 in the regulation of the capacity for DCs to mediate innate immune response. Jak2-/- DCs were found to be less potent in response to inflammatory stimuli (Figures 1E & 1F), and furthermore, they showed significant reduced capacity to secrete proinflammatory cytokines such as TNFalpha and IL-12 upon LPS stimulation (Figure 2A). As a result, Jak2-/- mice were defective for the early clearance of Listeria after infection as compared with that of control mice (Figure 2C). However, their potency to mediate adaptive immune response such as the capacity to activate allogenic or antigen specific T cells was not affected (Figures 3A-C). Very interestingly, it appears that Jak2 regulation of innate immune response is DC-dependent as macrophages deficient for Jak2 showed similar capacity secretion of proinflammatory cytokines such as TNFalpha and IL-12 (Figure 2B). This discrepancy could be caused by the difference for the STAT activation profile between DCs and macrophages. For example, Jak2 deficiency affected the activation of STAT3, 4, 5 and 6 in DCs (Figure 5), while defective activation was only noted for STAT3 and 4 in Jak2-/- macrophages (Figure S7). Together, our data suggest that Jak2 selectively modulates innate immune response which appears to be DC-dependent.
###end p 42
###begin p 43
###xml 844 848 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Park2">[41]</xref>
###xml 1378 1381 1374 1377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1374 1381 1370 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1438 1447 1434 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g004">Figure 4A</xref>
###xml 1470 1473 1466 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1466 1473 1462 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1720 1729 1716 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s007">Figure S7</xref>
###xml 1797 1798 1793 1794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1847 1850 1843 1846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1843 1850 1839 1846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1874 1877 1870 1873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1870 1877 1866 1873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 1981 1990 1977 1986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g004">Figure 4B</xref>
###xml 2104 2107 2100 2103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2100 2107 2096 2103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 2324 2327 2316 2319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2320 2327 2312 2319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 2380 2389 2372 2381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g004">Figure 4C</xref>
###xml 2446 2449 2438 2441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2442 2449 2434 2441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 2468 2477 2460 2469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009593.s005">Figure S5</xref>
###xml 1288 1292 <span type="species:ncbi:10090">mice</span>
###xml 1382 1386 <span type="species:ncbi:10090">mice</span>
###xml 1474 1478 <span type="species:ncbi:10090">mice</span>
###xml 1851 1855 <span type="species:ncbi:10090">mice</span>
###xml 1878 1882 <span type="species:ncbi:10090">mice</span>
###xml 2108 2112 <span type="species:ncbi:10090">mice</span>
###xml 2328 2332 <span type="species:ncbi:10090">mice</span>
###xml 2462 2466 <span type="species:ncbi:10090">mice</span>
To further dissect the role of Jak2 in DC-mediated innate immune response, we used septic shock, a typical disorder characterized by the uncontrolled innate immune response, as a model for the study. Septic shock is a severe sepsis due to excessive release of proinflammatory cytokines such as TNFalpha and IL-12, which then lead to vasodilation, increased vascular permeability, hypotension, multiple organ failure and ultimately shock and death. Unlike septic death resulted from late phase of sepsis, septic shock is manifested by excessive innate immune response such as copious amount of proinflammatory cytokine release. Therefore, Jak2 signaling might be a potential therapeutic target for controlling excessive innate immune response during septic shock. Cecal ligation and puncture (CLP) is a widely used experimental model for sepsis [41]. However, animals die after CLP usually ranging from 24 h to 7 days which implicates both altered innate immune response and maladaptive immune response. Since our focus is to determine Jak2 deficiency in DC-mediated innate immune response, it would be crucial to ultimately exclude the implication of adaptive immune response. As a result, we have chosen lethal dose of LPS-induced septic shock for the study. As expected, 78% of control mice died from septic shock within 36 h of lethal dose of LPS challenge, while 85% of Jak2-/- mice have survived from the same dose of LPS challenge (Figure 4A), indicating that Jak2-/- mice were protected from LPS-induced septic shock. Adoptive transfer studies were then applied to further address that this protective effect is DC-dependent. Since macrophages deficient for Jak2 only showed defective activation for STAT3 and 4 (Figure S7), we selected adoptive transfer of DCs for the study, in which 1x107 normal DCs were transferred into irradiated Jak2-/- mice. As expected, Jak2-/- mice after adoptive transfer of normal DCs showed restored susceptibility to LPS-induced septic shock (Figure 4B). These results demonstrate that DCs with reduced capacity for initiation of innate immune response rendered Jak2-/- mice more resistant to LPS-induced septic shock. In consistent with this conclusion, ELISA analysis of serum cytokines revealed significant lower levels of proinflammatory cytokines such as TNFalpha and IL-12 in Jak2-/- mice after 12 h of nonlethal dose of LPS challenge (Figure 4C), while the production of IL-10 was similar between Jak2-/- and control mice (Figure S5).
###end p 43
###begin p 44
###xml 87 90 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 83 90 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 224 233 220 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g004">Figure 4C</xref>
###xml 360 364 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Granucci1">[42]</xref>
###xml 365 369 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Granucci3">[44]</xref>
###xml 719 723 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Villarino1">[45]</xref>
###xml 748 753 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat5</italic>
###xml 835 838 831 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 831 838 827 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 956 960 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Granucci1">[42]</xref>
###xml 962 966 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Granucci4">[46]</xref>
###xml 1015 1018 1011 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1011 1018 1007 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
Of note, unlike TNFalpha and IL-12, we noticed much higher levels of serum IL-2 in Jak2-/- mice after LPS challenge as compared with control mice, although the absolute IL-2 level was relatively low in both strains of mice (Figure 4C). Recent studies demonstrated that microbial stimuli (not proinflammatory cytokines) are able to induce IL-2 secretion by DCs [42]-[44], while we failed to detect IL-2 secretion in DCs following LPS stimulation which could be due to the differences of our culture system or lower sensitivity of our detection system. Given the important regulatory role exerted by IL-2 in the immune system, it has been suggested to be tightly regulated by the STAT5-dependent negative feedback signal [45]. Therefore, the reduced Stat5 activity probably contributes to the observed higher levels of serum IL-2 in Jak2-/- mice. Studies have shown that DC-derived IL-2 plays a pivotal role in their capability to prime alloreactive T cells [42], [46], and therefore, enhanced IL-2 production in Jak2-/- DCs probably contributes to their unchanged potency to stimulate allogenic or antigen specific T cell activation as well.
###end p 44
###begin p 45
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g005">Figure 5</xref>
###xml 480 484 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Leonard1">[47]</xref>
###xml 675 678 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 671 678 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 796 804 792 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6</xref>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
Given the important role of Jak2 in cell signaling, we anticipate that Jak2 deficiency would affect the activation of multiple signaling pathways of DCs. Unexpectedly, we only detected altered activity for Stat3, 4, 5 and 6 (Figure 5). It seems that loss of Jak2 in DCs has negligible impact on Stat1 and NFkappaB signaling, which could be due to the compensated effect from other redundant Jak kinases. For example, other than Jak2, Stat1 can be activated by either Jak1 or Tyk2 [47]. Using Stat5-Tg mice, we have demonstrated evidence indicating that Jak2/STAT5 is indispensable for DC development and maturation in response to inflammatory stimulation. In opposite to Jak2-/- mice, Stat5-Tg mice displayed higher DC yield, larger spleen size and higher potency in response to LPS stimulation (Figure 6). However, Jak2/STAT5 only partly regulates DCs secretion of IL-12, indicating additional signaling pathway(s) that are also implicated in the regulation of DCs secretion of proinflammatory cytokines.
###end p 45
###begin p 46
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 290 293 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 285 293 281 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 339 342 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 334 342 330 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 396 405 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figure 6E</xref>
###xml 623 626 611 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 618 626 606 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4<sup>&#8722;/&#8722;</sup></italic>
###xml 667 672 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat3</italic>
###xml 804 818 792 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009593-g006">Figures 6E &amp; F</xref>
###xml 882 886 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Egwuagu1">[48]</xref>
###xml 887 891 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Park3">[51]</xref>
###xml 1099 1103 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Coffer1">[37]</xref>
###xml 1104 1108 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Park1">[39]</xref>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
To examine the possible implication of additional signaling pathway(s), we performed studies in Stat6-/- mice and demonstrated a pivotal role for Jak2/STAT6 signaling in the regulation of cytokine secretion in DCs. We noticed a significant impaired production of TNFalpha and IL-12 in Stat6-/- DCs following LPS stimulation, although Stat6-/- DCs secreted relatively higher baseline of TNFalpha (Figure 6E). Based on the results for TNFalpha and IL-12 production, there is no doubt that Jak2/STAT6 signaling regulates the capacity of DCs secretion of proinflammatory cytokines. We further performed similar studies in Stat4-/- mice and DC2.4 cells transfected with a Stat3 siRNA. Surprisingly, we failed to detect any perceptible impact for STAT3 and STAT4 on the capacity of DCs for cytokine secretion (Figures 6E & F). Given the importance of STAT4 pathway in T cell polarization [48]-[51], Jak2/STAT4 signaling could be implicated in the regulation of DCs to mediate T cell polarization. On the other hand, STAT3 has been recently suggested to be important for DC development and differentiation [37]-[39], and therefore, Jak2/STAT3 could work together with Jak2/STAT5 signaling to implicate in DC development.
###end p 46
###begin p 47
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Sayyah1">[52]</xref>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
Extensive studies have been conducted for decades to demonstrate the function of Jak2 in immune cells including DCs by using different Jak2 inhibitors. Results derived from these studies, however, remained controversial, because of non-specificity of each Jak2 inhibitor. To our knowledge, the present report is the first study carried out in adult mice deficient for Jak2. Due to the complexity of Jak2 in the regulation of immune responses, we have limited our current study to APCs, particularly, to DC-mediated innate immune response. The implication of Jak2 in the regulation of adaptive immunity is yet to be determined. We are also aware that Jak2 is essential for the development and functionality of other immune cells such as T and B cells. Future studies focused on demonstrating these questions would shed light to the development of novel therapeutic approaches to diseases such as cancer and autoimmune disorders [52].
###end p 47
###begin p 48
###xml 330 334 <span type="species:ncbi:10090">mice</span>
In conclusion, we have demonstrated the function of Jak2 in the regulation of DC development, maturation and cytokine secretion. Our data strongly support that Jak2 only selectively regulates the capacity of DCs to initiate innate immune response, while their capacity to stimulate T cell activation is not impacted. As a result, mice deficient for Jak2 show a DC-dependent resistance to lethal dose of LPS-induced septic shock, a deadly disorder caused by the excessive innate immune response. Together, our data suggest that Jak2 could be a unique therapeutic target for the intervention and treatment of clinical septic shock.
###end p 48
###begin title 49
Materials and Methods
###end title 49
###begin title 50
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 50
###begin p 51
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4<sup>&#8722;/&#8722;</sup></italic>
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H-2<sup>d</sup></italic>
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6<sup>&#8722;/&#8722;</sup></italic>
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H-2<sup>d</sup></italic>
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H-2<sup>d</sup></italic>
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H-2<sup>b</sup></italic>
###xml 188 193 188 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 184 193 184 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>fl/fl</sup></italic>
###xml 203 204 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H-2<sup>b</sup></italic>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H-2<sup>b</sup></italic>
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H-2<sup>d</sup></italic>
###xml 298 299 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H-2<sup>b</sup></italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 112 127 <span type="species:ncbi:10090">transgenic mice</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">H-2b</span>
###xml 216 220 <span type="species:ncbi:10090">H-2b</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 278 293 <span type="species:ncbi:10090">transgenic mice</span>
###xml 295 299 <span type="species:ncbi:10090">H-2b</span>
Stat4-/- (H-2d), Stat6-/- (H-2d) and BALB/cJ (H-2d) mice were purchased from the Jackson's Laboratory. Cre-ERT2 transgenic mice under the control of human ubiquitin C promoter (H-2b), Jak2fl/fl mice (H-2b), C57/BL6 (H-2b) mice, Stat5b transgenic (Stat5-Tg) mice (H-2d) and OT-1 transgenic mice (H-2b) were bred and housed in the SPF facility of Medical College of Georgia (MCG). All studies were carried out in compliance with MCG and Tongji Medical College Animal Care and Use Committee guidelines.
###end p 51
###begin title 52
Induction of Jak2 Deficiency
###end title 52
###begin p 53
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 10 15 10 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/+</sup>Jak2<sup>fl/fl</sup></italic>
###xml 217 220 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 224 229 224 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 214 229 214 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre<sup>+/+</sup>Jak2<sup>fl/fl</sup></italic>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:381124">corn</span>
###xml 272 276 <span type="species:ncbi:381124">corn</span>
Cre+/+Jak2fl/fl mice were intraperitoneally (i.p.) injected with tamoxifen (25 mg/kg body weight) for 5 consecutive days. Tamoxifen was freshly dissolved in corn oil supplemented with 10% ethanol before injection. Cre+/+Jak2fl/fl littermates injected with equal volume of corn oil with 10% ethanol were served as controls.
###end p 53
###begin title 54
Generation of BMDCs
###end title 54
###begin p 55
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 460 464 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Huang1">[53]</xref>
Bone marrow cells were flushed from femurs and tibias, and 5x105/ml cells were plated in 150-mm Petri dishes and cultured with RPMI-1640 supplemented with 10% FCS, GM-CSF (10 ng/ml) and IL-4 (5 ng/ml) (PeproTech, Rocky Hill, NJ). Suspended cells were discarded at day-4 and the cultures were replaced with fresh media at day-7. BMDCs were then stimulated with LPS (0.5 microg/ml, Sigma, St Louis, MO) overnight and harvested on day-10 for experimental purpose [53].
###end p 55
###begin title 56
Isolation of PEM
###end title 56
###begin p 57
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Kumar1">[54]</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
PEM were collected by peritoneal lavage as reported with minor modifications [54]. Briefly, mice were i.p. injected with 5 ml sterilized cold RPMI 1640. PEM were harvested by washing peritoneal lavage twice with 5 ml cold RPMI 1640. After lysis of red blood cells, the cells were incubated for 3 h at 37degreesC in 35x15 mm culture dishes. Non-adherent cells were removed by exhaustive washing with 1 x PBS and the adherent cells were collected for experimental purpose.
###end p 57
###begin title 58
Western Blot Analysis
###end title 58
###begin p 59
###xml 388 392 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Guo1">[55]</xref>
Total proteins were prepared from BMDCs or splenocytes using RIPA lysis buffer supplemented with protease inhibitors. Western blot analysis was carried out as reported by probing the blots with an indicated primary Ab (Santa Cruz, CA) followed by an HRP-conjugated secondary antibody. The reactive bands were visualized using an ECL Plustrade mark Western blot kit (PIERCE, Rockford, IL) [55]. beta-actin was used for normalization. All Western blotting antibodies were purchased from Santa Cruz.
###end p 59
###begin title 60
Flow Cytometry Analysis
###end title 60
###begin p 61
###xml 184 185 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 220 224 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Yu1">[56]</xref>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
BMDCs or splenic single cell suspensions were prepared and washed with PBS. After blocking with anti-mouse CD16/32 Fcgamma III/II receptor, the cells were stained for CD11c, CD11b, I-Ad, CD80, CD86, and CD54 as reported [56]. After washes, the cells were suspended in FACS buffer and analyzed on a FACSCalibur (BD Bioscience, San Jose, CA). The data were analyzed using CellQuest v3.3 software as instructed. All flow cytometry antibodies were purchased from BD Bioscience.
###end p 61
###begin title 62
ELISA Analysis of Cytokines
###end title 62
###begin p 63
###xml 180 184 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Han1">[57]</xref>
The amount of TNFalpha, IL-2, IL-10, IL-12, IL-17 and IFN-gamma in the culture media and sera was determined using the sandwich ELISA kits (eBioscience, San Diego, CA) as reported [57].
###end p 63
###begin title 64
Mixed Lymphocyte Reaction (MLR)
###end title 64
###begin p 65
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 287 290 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 380 381 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 426 427 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 457 460 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 453 460 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 550 551 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 769 773 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Han1">[57]</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 586 601 <span type="species:ncbi:10090">transgenic mice</span>
Splenic DCs originated from Jak2-/- and control mice were purified using a mouse DC enrichment kit (StemCell, Seattle, WA). For allogenic MLR, T cells isolated from BALB/cJ mice were co-cultured with irradiated (2000 rad) BMDCs or splenic DCs (2x105/ml, DC:T = 1:10) originated from Jak2-/- or control mice for 56 h followed by additional 16 h in the presence of 0.5 microCi/well 3H thymidine. For antigen-specific MLR, 2.5x105/ml irradiated (2000 rad) Jak2-/- BMDCs or splenic DCs were pulsed with 1 microM OVA peptide and then co-cultured with 5x105/ml splenocytes isolated from OT-1 transgenic mice as above. After washes, the cells were finally harvested on glass wool filters with a suction-water-wash apparatus, dried, and counted in a beta scintillation counter [57]. T cell proliferation was estimated as mean CPM (counts per minute) +/- SE.
###end p 65
###begin title 66
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 0 22 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Listeria monocytogenes Infection
###end title 66
###begin p 67
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 77 79 65 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 81 103 69 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria Monocytogenes</italic>
###xml 124 132 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 175 179 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Pope1">[58]</xref>
###xml 181 185 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Harty1">[59]</xref>
###xml 204 226 192 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria Monocytogenes</italic>
###xml 298 302 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009593-Harty1">[59]</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Jak2-/- and control mice were i.v. injected with 1x106 CFU (approximately1 LD50) Listeria Monocytogenes (LM-ova, a modified Listeria strain expressing OVA) in PBS as reported [58], [59]. Determination of Listeria Monocytogenes titer was carried out as previously described with minor modifications [59]. Briefly, spleens and livers were harvested after 48 h infection and homogenized in sterile distilled water containing 0.2% triton X-100. After 30 min incubation at room temperature, serial 10-fold dilutions were plated on TSB-agar and incubated at 37degreesC. Colonies were counted after 48 h incubation.
###end p 67
###begin title 68
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat3</italic>
Stat3 siRNA Transfection in DC2.4 Cells
###end title 68
###begin p 69
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat3</italic>
DC2.4 cells were transfected with a Stat3 siRNA or a scramble RNA (Santa Cruz, CA) as instructed by the manufacturer. The cells were stimulated with 0.5 microg/ml LPS after 24 h transfection. Cell lysates and culture supernatants were then subjected to Western blot and ELISA analysis after 24 h stimulation, respectively.
###end p 69
###begin title 70
Induction of LPS-Challenged Septic Shock
###end title 70
###begin p 71
###xml 398 401 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 394 401 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Jak2<sup>&#8722;/&#8722;</sup></italic>
###xml 485 486 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">Mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
For induction of septic shock, the mice were first i.p. injected with 50 mg/kg body weight of LPS (Sigma, St Louis, MO), and then subjected to evaluation of mortality and behavior changes every 6 h for >96 h. Mice injected with 150 microg LPS were used as a model for nonlethal sepsis. Serum samples were collected using whole blood after 12 h of injection. For adoptive transfer studies, both Jak2-/- and control mice were first underwent 800 rads of irradiation. Two days later, 1x107 BMDCs derived from nonirradiated control mice were injected into these irradiated mice via tail vein, respectively. After 4 h of transfer, the mice were underwent induction of septic shock with lethal dose of LPS (25 mg/kg body weight) as above. Eight mice were included in each study group.
###end p 71
###begin title 72
Statistical Analysis
###end title 72
###begin p 73
###xml 80 95 80 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chi-square test</italic>
###xml 346 347 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Survival curves for septic shock were generated by the Kaplan and Meier method. Chi-square test was employed to determine the difference of mortality for LPS-induced septic shock. Comparisons between groups for flow cytometry, cytokine and MLR data were accomplished by one-way ANOVA using SPS 11.5 for windows. Data were present as mean +/- SE. P<0.05 was considered statistically significant.
###end p 73
###begin title 74
Supporting Information
###end title 74
###begin p 75
Loss of Jak2 suppresses the maturation of splenic DCs. Surface marker expressions were analyzed by flow cytometry in splenic DCs. Each bar represents the average percentage of DCs positive for the surface marker analyzed.
###end p 75
###begin p 76
(0.12 MB TIF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
###xml 95 99 <span type="species:ncbi:10090">mice</span>
AG490 suppresses BMDC maturation in a dose-dependent manner. Bone marrow cells derived from B6 mice were used to generate BMDCs. AG490 (0, 100 and 200 microM, respectively) was added into the cultures on day-4. BMDCs were stimulated with LPS (500 ng/ml) on day-9 and harvested on day-10 for flow cytometry analysis of surface marker expressions. Left panel: a representative flow cytometry data of three independent experiments performed; right panel: a bar graphic figure showing the average percentage of BMDCs positive for each surface marker analyzed. *, p<0.05.
###end p 78
###begin p 79
(4.21 MB TIF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Tamoxifen does not have perceptible effect on DC phenotype. 25 mg/kg body weight of tamoxifen or carrier solution were i.p. injected into B6 mice for 5 consecutive days. The mice were sacrificed after 2 wk of last injection. Bone marrow cells were used to generate BMDCs and surface marker expressions were analyzed before/after LPS stimulation.
###end p 81
###begin p 82
(0.67 MB TIF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
Loss of Jak2 suppresses surface marker expressions in macrophages. Macrophages deficient for Jak2 show less matured phenotype. Each bar represents the average percentage of macrophages positive for each surface marker analyzed.
###end p 84
###begin p 85
(0.13 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
IL-10 secretion after LPS challenge (A) ELISA analysis of IL-10 production of culture supernatants derived from Jak2-/- and wild-type BMDCs before/after LPS (1 microg/ml) treatment. (B) Serum IL-10 levels after LPS challenge. Both Jak2-/- and control mice were first challenged with nonlethal dose of LPS (150 microg/mouse) and 12 h later the mice were sacrificed. Sera were pooled from three mice and then subjected to ELISA analysis of IL-10.
###end p 87
###begin p 88
(0.12 MB TIF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 373 378 <span type="species:ncbi:10090">mouse</span>
Flow cytometry analysis of apoptotic BMDCs and splenic DCs after LPS challenge (A) BMDC apoptosis after LPS stimulation. BMDCs were stimulated 10 microg/ml LPS for 96 h and then stained with Annexin-V and PI followed by flow cytometry analysis of apoptotic cells. (B) Splenic DC apoptosis after LPS challenge. Jak2-/- and control mice were first challenged with 150 microg/mouse of LPS and were sacrificed after 20 h of injection. Splenic DC apoptosis was then analyzed by flow cytometry as above.
###end p 90
###begin p 91
(0.11 MB TIF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
Western blot analysis of the activation states of Jak2 downstream molecules in macrophages. Only STAT3 and STAT4 showed defective activation in Jak2-/- macrophages.
###end p 93
###begin p 94
(0.16 MB TIF)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
We would like to thank Dr. X. Rao (Medical College of Georgia) for assistance and experimental advice.
###end p 96
###begin title 97
References
###end title 97
###begin article-title 98
Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes.
###end article-title 98
###begin article-title 99
Dendritic cells: translating innate to adaptive immunity.
###end article-title 99
###begin article-title 100
The interplay of innate immunity, adaptive immunity, and autoimmunity.
###end article-title 100
###begin article-title 101
The interface between innate and adaptive immunity.
###end article-title 101
###begin article-title 102
The immunology of sepsis.
###end article-title 102
###begin article-title 103
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Selective defects of T lymphocyte function in patients with lethal intraabdominal infection.
###end article-title 103
###begin article-title 104
###xml 31 39 <span type="species:ncbi:9606">patients</span>
T helper cell subset ratios in patients with severe sepsis.
###end article-title 104
###begin article-title 105
The chronic consequences of severe sepsis.
###end article-title 105
###begin article-title 106
The immunopathogenesis of sepsis.
###end article-title 106
###begin article-title 107
Mechanisms of mortality in early and late sepsis.
###end article-title 107
###begin article-title 108
Critical advances in septicemia and septic shock.
###end article-title 108
###begin article-title 109
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation.
###end article-title 109
###begin article-title 110
###xml 32 39 <span type="species:ncbi:9606">patient</span>
Recognizing sepsis in the adult patient.
###end article-title 110
###begin article-title 111
The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertiary-care university hospital setting.
###end article-title 111
###begin article-title 112
Early- versus late-onset shock in European intensive care units.
###end article-title 112
###begin article-title 113
Sepsis and the dendritic cell.
###end article-title 113
###begin article-title 114
Jak2: normal function and role in hematopoietic disorders.
###end article-title 114
###begin article-title 115
Jak2 tyrosine kinase: a true jak of all trades?
###end article-title 115
###begin article-title 116
Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance.
###end article-title 116
###begin article-title 117
JAK/STAT signaling by cytokine receptors.
###end article-title 117
###begin article-title 118
Roles of the JAK-STAT system in signal transduction via cytokine receptors.
###end article-title 118
###begin article-title 119
Regulation of JAK-STAT signalling in the immune system.
###end article-title 119
###begin article-title 120
JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
###end article-title 120
###begin article-title 121
Jak2 is essential for signaling through a variety of cytokine receptors.
###end article-title 121
###begin article-title 122
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency.
###end article-title 122
###begin article-title 123
Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.
###end article-title 123
###begin article-title 124
Activation of dendritic cells via inhibition of Jak2/STAT3 signaling.
###end article-title 124
###begin article-title 125
Innate defenses in the liver during Listeria infection.
###end article-title 125
###begin article-title 126
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 129 151 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.
###end article-title 126
###begin article-title 127
###xml 123 145 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice.
###end article-title 127
###begin article-title 128
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.
###end article-title 128
###begin article-title 129
Using innate immunity to characterize the host response to microbial invasion in severe sepsis.
###end article-title 129
###begin article-title 130
Sepsis and innate immunity.
###end article-title 130
###begin article-title 131
[Innate immunity, Toll receptor and sepsis].
###end article-title 131
###begin article-title 132
Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway.
###end article-title 132
###begin article-title 133
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.
###end article-title 133
###begin article-title 134
The role of STATs in myeloid differentiation and leukemia.
###end article-title 134
###begin article-title 135
Control of myeloid differentiation and survival by Stats.
###end article-title 135
###begin article-title 136
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
###end article-title 136
###begin article-title 137
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.
###end article-title 137
###begin article-title 138
CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
###end article-title 138
###begin article-title 139
Inducible IL-2 production by dendritic cells revealed by global gene expression analysis.
###end article-title 139
###begin article-title 140
Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity.
###end article-title 140
###begin article-title 141
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming.
###end article-title 141
###begin article-title 142
Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals.
###end article-title 142
###begin article-title 143
IL-2 mediates adjuvant effect of dendritic cells.
###end article-title 143
###begin article-title 144
Jaks and STATs: biological implications.
###end article-title 144
###begin article-title 145
STAT3 in CD4+ T helper cell differentiation and inflammatory diseases.
###end article-title 145
###begin article-title 146
Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases.
###end article-title 146
###begin article-title 147
Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells.
###end article-title 147
###begin article-title 148
CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
###end article-title 148
###begin article-title 149
Jak2 inhibitors: rationale and role as therapeutic agents in hematologic malignancies.
###end article-title 149
###begin article-title 150
###xml 73 79 <span type="species:ncbi:10090">murine</span>
Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection.
###end article-title 150
###begin article-title 151
###xml 40 46 <span type="species:ncbi:10090">murine</span>
Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptide JT3002.
###end article-title 151
###begin article-title 152
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes.
###end article-title 152
###begin article-title 153
Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
###end article-title 153
###begin article-title 154
###xml 134 138 <span type="species:ncbi:10090">mice</span>
Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice.
###end article-title 154
###begin article-title 155
###xml 56 78 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection.
###end article-title 155
###begin article-title 156
###xml 54 76 <span type="species:ncbi:1639">Listeria monocytogenes</span>
CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo.
###end article-title 156
###begin p 157
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 157
###begin p 158
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Juvenile Diabetes Research Foundation (JDRF, 1-2007-181 and 1-2007-192) and NIH/NIDDK (DK074957) to CYW, and supported in part by the National Key Basic Research Program of China (2007CB512402) to FG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 158

